Hashimoto Teppei Department
Specialty Division
, Clinical Medicine Seminars
Position
■ Journal
1.
Introduction
Cell-Free DNA in rheumatoid arthritis. 2021/08
2.
Original article
Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis. 2022/01
■ Presentation
1.
Systemic Immune-inflammation index in rheumatoid arthritis patients:relation to disease activity. 2019/06/13
2.
Circulating cell free DNA released from eosinophils is a practical biomarker in patients with eosinophilic granulomatosis with polyangiitis. 2019/11/11
3.
Relationship between YKL-40, VEGF, and IL-5 in borderline mPAP and pulmonary hypertension in systemic sclerosis. 2019/11/11
4.
Increased levels of serum wisteria floribunda agglutininpositive Mac-2 binding protein in rheumatic diseases including SLE. 2021/06/02
5.
Successful treatment of checkpoint inhibitor-induced arthritis with the IL-6 receptor inhibitor Sarilumab. 2021/08/28
6.
Plasma cell-free DNA is a useful biomarker for tocilizumab therapy in rheumatoid arthritis. 2021/11/08
7.
Neutrophil count reduction 1month after initiating sarilumab and baseline serum soluble gp130 levels can independently predict clinical remission within 3 month in rheumatoid arthritis patients. 2022/06/01
8.
The baseline serum soluble TNF receptor level are associated with the response of rheumatoid arthritis
patients to JAKinibs. 2022/06/01